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Low Level Light Therapy (LLLT) within the visible blue 
spectrum (400-470 nanometers) is a well-documented 
therapeutic alternative to combat multidrug resistant 
organism infections through the generation of reactive 
oxygen species (ROS). However, one shortcoming of 
LLLT is that many studies deliver therapy through high 
powered lasers and lamps. High powered light sources 
not only require specialized staff to operate, but they also 
deliver the total light dose (fluence) at an exceptionally 
high intensity, or irradiance, which could consequently 
deplete the oxygen supplies required to promote LLLT’s 
bactericidal properties. To overcome these faults, low-
irradiance LLLT, or delivering the same total fluence of 
LLLT over an extended period of time with decreased 
irradiance was evaluated in vitro. To further explore 
this alternative approach, the bactericidal effects of low-
irradiance (10.44 mW/cm2) LLLT using wavelengths 
of 405-nm, 422-nm and 470-nm were studied on 
methicillin-resistant Staphylococcus aureus (MRSA) 
cultures. Among these wavelengths, it was determined 
that 405-nm LLLT provided the most effective reduction 
of bacterial load at the lowest total fluence (75 J/cm2) 
(94.50% reduction). The bactericidal effects of 405-nm 
low-irradiance LLLT were then further studied by 
treating MRSA cultures to 75 J/cm2 LLLT while using 
irradiances of 5.22 mW/cm2 and 3.48 mW/cm2. It was 
concluded that there was a greater reduction of MRSA 
bacterial load when samples were exposed to irradiances 
of 5.22 mW/cm2 (95.71% reduction) and 3.48 mW/cm2 
(99.63% reduction). This study validates the bactericidal 
properties of low-irradiance LLLT on MRSA, and 
subsequent studies should be completed to optimize its 
full therapeutic potential.
ABSTRACT
CORRESPONDING 
AUTHOR
Patrick J. McMullan
pjm4302@rit.edu
KEYWORDS
• Photoinactivation
• bactericidal 
• MRSA
• Low Level Light Therapy
The plight of antibiotic resistance, partially 
due to the medical community’s overreliance 
of antibiotics, has led to efforts by healthcare 
systems to determine alternative strategies 
for antimicrobial treatments. In the United 
States, there are more than 2 million cases 
of hospital-acquired infections (HAIs) 
annually, resulting in annual costs of $20 
billion and nearly 100,000 deaths (16,26). 
Methicillin-resistant Staphylococcus aureus 
INTRODUCTION
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(MRSA) is one of the prominent pathogens 
involved with both HAIs and community 
acquired infections (CAIs). The prevalence 
of an individual within the intensive care 
unit who develops either a HAI or CAI 
due to MRSA are greater than 55% and 
59%, respectively (10). MRSA has been 
able to ascend to its present status as a 
predominant infective agent due to its ability 
to develop high levels of resistance to several 
classes of antibiotics through different 
pathways, including mutation, conjugation, 
transduction, and transformation (2).
There are two distinct sources of MRSA: 
(1) hospital-associated MRSA (HA-MRSA), 
which are limited to clinical settings, and 
(2) community-associated MRSA (CA-
MRSA), which are found in a multitude 
of environments and settings, including 
beaches, computer keyboards, schools, 
gyms, athletic fields, and locker rooms. (5-
7). MRSA, an opportunistic pathogen, is not 
only responsible for localized trauma or 
postoperative infections, but can also be life-
threatening, causing bacteremia, endocarditis, 
sepsis or toxic-shock syndrome (11,13,17). 
Research also suggests MRSA is one of the 
primary pathogens responsible for failure of 
surgical implants or prosthetics due to biofilm 
formation at the soft-tissue-implant interface, 
which compromises patients’ activities of 
daily living (ADLs), as well as causes re-
implantation to eliminate the bacterial load 
(28).
A long-term solution to better manage 
multidrug-resistant organism infections 
is paramount. Low Level Light Therapy 
(LLLT), also referred to as “biostimulation,” 
is the process of illuminating tissues with a 
precise wavelength of light over a specific 
period of time. More specifically, the use of 
high energy (lower wavelength) waves in 
the ultraviolet (UV) and visible blue spectra 
for LLLT have shown more consistent 
results when it comes to bactericidal 
effects and reduction of bioburden. The 
capabilities of UV (100-400nm) LLLT to 
sterilize wound surfaces has been well-
documented (3,8-9,15). Dai et al. investigated 
the potential of prophylactic UV (200-
280nm) light treatment for infections 
developing in superficial cutaneous mouse 
wounds contaminated with both MRSA 
and Pseudomonas aeruginosa (9). For both 
bacterial infections, UV LLLT significantly 
reduced the bacterial burden in comparison 
to untreated wounds, while also increasing 
the survival rate of P. aeruginosa infected 
mice (58%) and wound-healing rate 
of MRSA infected mice (31%) (9). However, 
a limitation to UV LLLT is that it is toxic 
and carcinogenic in tissues with extended 
exposure (3,8-9,15).  
In order to overcome the collateral damage 
associated with UV LLLT, the use of 
wavelengths in the visible blue spectrum 
(400-470-nm) have been proven to be 
efficacious for both their bactericidal and 
wound healing capabilities in vitro and in 
vivo (1,10,19-20,23,27). While UV LLLT’s 
bactericidal properties are induced through 
DNA damage, the mechanism of visible 
blue light involves the photoexcitation of 
endogenous porphyrins within bacterial 
species, which is much less detrimental 
to healthy mammalian cells (1,10,19-20,23, 
27). Subsequently, this excitation initiates 
the formation of reactive oxygen species 
(ROS), which are toxic to bacterial cells and 
biofilms, without compromising the DNA 
of adjacent cells. Maclean et al. investigated 
the bactericidal effects of visible (405-nm) 
light using a high-intensity xenon lamp, 
and illustrated that the 405-nm array had 
a phototoxic effect on a variety of bacteria 
that are highly prevalent in CAIs and HAIs, 
including Gram-positive bacteria: MRSA, 
Staphylococcus epidermidis, Streptococcus 
pyogenes, Clostridium perfringens, and 
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Gram-negative bacteria: Acinetobacter 
baumannii, Pseudomonas aeruginosa, 
Escherichia coli, Proteus vulgaris and 
Klebsiella pneumonia (19). 
The first underlying objective of this study 
was to compare the bactericidal efficacy 
of LLLT on cultures of MRSA using three 
specific wavelengths (405-nm, 422-nm 
and 470-nm) within the visible blue 
spectrum. Additionally, the objective of 
this study was to evaluate the efficacy of 
low-irradiance LLLT, or the concept of 
delivering the same total light dose, or 
fluence, of LLLT at a lower intensity, or 
irradiance, over an extended period of 
time. This concept contradicts standard 
LLLT where therapy is administered at a 
considerably high irradiance (>40 mW/
cm2) and delivered over a period of 
seconds to 15 minutes (10, 14). 
Based on these objectives, this in vitro study 
was conducted in two separate phases. 
In phase 1, the bactericidal properties of 
405-nm, 422-nm and 470-nm LLLT were 
evaluated to determine which wavelength 
provided the greatest bacterial load reduction 
at the lowest possible fluence. MRSA samples 
were exposed to these three wavelengths at 
an irradiance of 10.44 mW/cm2, which is 
substantially lower than precedent studies 
(10, 14). After determining the optimal 
wavelength and the precise fluence, phase 
2 was conducted by evaluating the efficacy 
of low-irradiance LLLT at the optimal 
wavelength, but at irradiances of 5.22mW/
cm2 and 3.48 mW/cm2, and durations of 4 
and 6 hours. Given the recent advancement 
of implantable and portable LLLT devices (4, 
25), the process of administering LLLT over 
a period of multiple hours has the potential 
to be a cost-effective yet clinically feasible 
alternative to conventional LLLT. 
Despite the fact LLLT’s bactericidal effects 
have been well documented within all 
wavelengths of the visible blue spectrum, 
it is hypothesized that 405-nm LLLT 
will provide the greatest bactericidal 
response, due to the higher energy levels 
associated with the shorter wavelength 
photons. Furthermore, it is expected 
that low-irradiance LLLT will provide a 
greater bactericidal rate when compared 
to delivering the same LLLT fluence at a 
higher-irradiance, because of the fact that 
visible blue LLLT is dependent upon oxygen 
supplies for ROS formation. Consequently, 
low-irradiance LLLT will not deplete 
oxygen supplies as rapidly and therefore 
provide greater treatment efficacy.
MATERIALS AND METHODS
STUDY DESIGN:
During phase 1, cultures of MRSA were 
exposed to three separate wavelengths of 
visible blue light (405-nm, 422-nm and 
470-nm) at an irradiance of 10.44 mW/
cm2. The cultures were exposed to LLLT for 
a total of 8 hours. However, aliquots from 
each of the exposed cultures were taken in 
two-hour intervals (t=2,4,6,8 hours), which 
was the equivalent of LLLT doses of 75 J/
cm2. These aliquots were then quantified to 
determine the number of colony forming 
units per milliliter (CFU/mL) through a 
standard plate counting technique using a 
Whitley Automated Spiral Plater (WASP). 
Table 1 outlines the total fluence of LLLT 
each culture received at each of the two-
hour intervals.  
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Upon completion of phase 1, a prospective 
analysis was conducted to determine which 
wavelength would provide the greatest 
bacterial load reduction at the lowest possible 
fluence. After determining these conditions, 
phase 2 was initiated to evaluate the effects 
of maintaining the aforementioned optimal 
fluence, but further reducing the irradiance 
and increasing the total exposure time of 
LLLT to 5.22 mW/cm2 (4 hour exposure) and 
3.48 mW/cm2 (6 hour exposure). 
BACTERIAL ISOLATES:  
The MRSA strain that was used in this 
procedure was ATCC(r) BAA-1761 (ATCC, 
Manassas, VA). A loopful of frozen inoculum 
from -80°C frozen stocks was used to 
quadrant streak onto the surface of a tryptic 
soy agar (TSA) plate.  Each plate was then 
incubated at 37°C and 5% CO2 for 24 hours 
to produce isolated and pure cultures of 
MRSA for this study.  
BIOSAFETY PRECAUTIONS:
Throughout the course of the procedure 
outlined within this experimental study, 
adequate biosafety measures were taken to 
comply with the fact that MRSA is classified 
under the Biosafety Level 2 Risk Group. 
In addition to wearing laboratory coats, 
gloves and eye protection, all facets of this 
procedure were conducted using aseptic 
technique within a Class II laminar flow 
biosafety cabinet. 
LIGHT EMITTING DEVICE: 
The LED light sources used during Phase 
1 of this study were LEDs at 405+5-nm, 
422+5-nm and 470+5-nm wavelengths 
(Visual Communications Company, Poway, 
CA). The light-emitting device was 
constructed by assembling LEDs onto 
an EIC-108 3220 Tie-Points Solderless 
Breadboard (EIC Laboratories INC., 
Norwood, MA).  A Labnet Power Station 
300 power supply (Labnet International, 
Edison, NJ) was connected to provide the 
desired voltages to emit the necessary 
irradiance. 24 LEDs were assembled onto 
each breadboard, and were then positioned 
directly beneath one well on a 24-well 
plate, so each well would be illuminated 
by a single LED. To ensure that each well 
was receiving identical irradiances of blue 
light, the overall irradiance that each well 
was illuminated by was measured using a 
THORLABS Optical Power Meter (Thor 
Laboratories, Newton, NJ). 
PHOTOINACTIVATION 
PROCEDURE: 
MRSA was grown for 24 hours at 37°C and 
5% CO2 in tryptic soy broth (TSB). After 
isolating colonies of MRSA, a single colony 
of MRSA was suspended in TSB to grow for 
24 hours. Following incubation, aliquots of 
the cultures were serially diluted in sterile 
saline to a final dilution factor of 1:10,000 
(TSB suspended MRSA culture: Saline). 
This dilution was completed in order to 
quantify the bacteria within the constraints 
of the Whitely Automatic Spiral Plating 
system outlined below. The concentration of 
MRSA in the diluted cultures was confirmed 
through monitoring their optical density 
(OD600) at 600-nm. 
275.0 µL of the diluted MRSA cultures were 
loaded into each well of a Corning® Costar® 
24-Well Flat Bottom Cell Culture Plate with 
a Total Well Volume of 3.4 mL (Corning 
Inc, Corning, NY) to receive light exposure. 
Throughout the course of this experiment, 
there were four separate trials conducted to 
ensure consistency, and to evaluate both the 
intraplate and interplate bactericidal effects 
of the low-irradiance LLLT.  During each 
individual trial in phase 1, there were four 
experimental cohorts where MRSA cultures 
received either: 1) no light exposure (control); 
2) 405-nm LLLT; 3) 422-nm LLLT; or 4) 
470-nm LLLT. For each cohort that received 
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LLLT, the light was administered at a fixed 
irradiance of 10.44 mW/cm2. During phase 
2, there were also found experimental 
cohorts where MRSA cultures received 
either: 1) no light exposure (control); 2) 
LLLT at 10.44 mW/cm2 over 2 hours; 3) 
LLLT at 5.22 mW/cm2 over 4 hours; or 
4) LLLT at 3.48 mW/cm2 over 6 hours. 
During phase 2, cultures that received LLLT 
were treated with the optimal wavelength 
determined during phase 1. With the 
exception of the light wavelengths from 
the LED source used on the experimental 
groups, each trial was completed at room 
temperature in total darkness to eliminate 
confounding variables from external light 
sources. Additionally, in order to minimize 
the risk for contamination, the well plates 
remained covered for the duration of the 
light treatment. Throughout the course of 
each trial, fifty-microliter aliquots were 
taken from four randomly selected wells 
using aseptic technique, although no well 
was repeatedly sampled, in each well plate 
during increments of 2 hours of light 
exposure. These aliquots were then plated 
onto TSA using the Whitley Automated 
Spiral Plating system. 
STANDARD PLATE COUNT 
PROCEDURE:  
A Whitley Automated Spiral Plater (WASP) 
(Don Whitley Scientific Limited, West 
Yorkshire, UK) was used to spiral plate 
50 µL of each aliquot onto the surface of 
a tryptic soy agar plate in an Archimedes 
spiral. The plates were incubated for 24 
hours at 37°C in 5% CO2. Colony counts 
were manually performed three times per 
plate, and the mean value was subsequently 
used to calculate the bacterial load in units 
of CFU/mL. 
STATISTICAL ANALYSIS
Data throughout the course of this study 
was analyzed post-hoc using one-
way ANOVA and Student t-tests. Each 
illumination condition was compared 
to their control, as well as wavelength 
differences between groups. P values < 
0.05 were considered to be statistically 
significant. 
RESULTS
As illustrated in Table 1 and Fig. 1, 405-
nm low-irradiance LLLT provided the 
greatest total bacterial load reduction of 
MRSA cultures (99.06% reduction [p < 
0.05]) in Phase 1, when compared to 422-
nm (98.84%) and 470-nm (98.71%) LLLT. 
Furthermore, 405-nm LLLT was the only 
wavelength that successfully provided a 
2.0-log bacterial load reduction (> 99.0% 
kill rate).
While 405-nm LLLT provided the greatest 
cumulative bacterial load reduction among 
the eight-hour light exposure, Table and 
Fig. 1 also suggest there was a greater 
bacterial load reduction seen from a 
fluence of 75 J/cm2 across the first two 
hours of 405-nm LLLT treatment (94.50% 
[p < 0.0001]) than what was seen from a 
fluence of 150 J/cm2 across the first four 
hours of 422-nm LLLT (83.47%), as well 
as 225 J/cm2 across the first six hours of 
470-nm LLLT (93.95%), respectively. Based 
on these observations, phase 2 of this study 
was conducted using the optimal LLLT 
wavelength of 405-nm at a fluence of 75 
J/cm2. 
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Figure 1. MRSA Colony Forming units 
(CFUs) Post-Low Level Light Therapy 
This figure is a graphical depiction 
of mean bacterial load reductions of 
MRSA following 405-nm, 422-nm and 
470-nm LLLT relative to the total LLLT 
fluence received. Each experiment was 
completed at a fixed irradiance of 10.44 
mW/cm2. MRSA samples were collected 
in increments of 75 J/cm2 (every 2 
hours of the 8-hour treatment) of LLLT. 
Error bars represent standard error of 
collected samples. Asterisks (****) signify  
p-value < 0.0001 following ANOVA to 
analyze significant differences between 
experimental wavelengths.
Fluence 
(J/cm2)
405-nm 422-nm 470-nm
log
(± SEM)
Percent 
Change
log
(± SEM)
Percent 
Change
log
(± SEM)
Percent 
Change
75 8.06 (± 0.03) 
[p < 0.0001]
94.50% 8.93 (± 0.02) 54.32% 9.10 (± 0.02) 36.87%
150 7.67 (± 0.02)
[p < 0.0001]
97.53% 8.46 (± 0.02) 83.47% 8.93 (± 0.03) 53.42%
225 7.31 (± 0.02)
[p <0.021]
98.93% 7.54 (± 0.02) 96.92% 8.15 (± 0.02) 93.95%
300 7.26 (± 0.02)
[p <0.05]
99.06% 7.36 (± 0.02) 98.84% 7.39 (± 0.02) 98.71%
Table 1. Bacterial Load Reduction of MRSA Samples Following 10.44 mW/cm2 LLLT: This 
table indicates the mean bacterial load reductions log(CFU/mL)(± SEM) of MRSA following 
low-irradiance LLLT at wavelengths of 405-nm, 422-nm and 470-nm. All samples were 
exposed to light at a constant irradiance of 10.44 mW/cm2, but received LLLT at varying 
exposure times and total fluences (J/cm2). A total of 16 replicates (4 from each experimental 
trial) of each data point were collected to determine mean bacterial load reductions.  
P-values signify level of significance differences among the experimental wavelengths using 
ANOVA. P-values < 0.05 are considered significant.  
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Upon determining the optimal fluence and 
wavelength of LLLT in Phase 1, Phase 2 
was conducted to analyze 405-nm LLLT 
when delivering the same total fluence of 
75 J/cm2, but through irradiances of 5.22 
mW/cm2 and 3.48 mW/cm2. By decreasing 
the irradiances, the duration of each LLLT 
cycle to receive 75 J/cm2 was increased 
from the initial two-hour treatment at 10.44 
mW/cm2 to 4 hours at 5.22 mW/cm2 and 6 
hours at 3.48 mW/cm2. 
Table 2 indicates that there was a correlation 
associated with a greater bacterial load 
reduction when an identical fluence of 75 
J/cm2 405-nm LLLT was administered at 
a lower irradiance and subsequently an 
increased exposure time. An increased 
bacterial load reduction was observed when 
the irradiance was decreased to 5.22 mW/
cm2 (95.71% reduction [p < 0.023]) and 3.48 
mW/cm2 (99.63% reduction [p < 0.0001]). 
Irradiance  
(mW/cm2)
LLLT Exposure 
Period
Mean Log  
(± Standard Error)
Mean Bacterial 
Load Reduction P-value
10.44 2 hours 8.06 (± 0.03) 94.50% -
5.22 4 hours 7.91 (± 0.04) 95.71% < 0.023
3.48 6 hours 6.85 (± 0.03) 99.63% < 0.0001
Table 2: Bacterial Load Reduction of MRSA Following Irradiance-Manipulated 405-nm 
LLLT: This table indicates the mean bacterial load reductions (CFU/mL) of MRSA following 
75 J/cm2 of 405-nm low-irradiance LLLT. While all samples received a constant fluence of 
75 J/cm2, the irradiance and exposure times were manipulated from 10.44 mW/cm2 to 5.22 
mW/cm2 and 3.48 mW/cm2. A total of 16 replicates (4 from each experimental trial) of each 
data point were collected to determine mean bacterial load reductions. P-values signify level 
of significance differences among the experimental irradiances using ANOVA. P-values < 
0.05 are considered significant.  
DISCUSSION
One significant limitation of conventional LLLT 
is that the high-intensity light sources that are 
commonly used to administer therapy are 
relatively expensive, and require a specialized 
medical facility and staff to operate and 
maintain. Consequently, these centers require 
frequent travel for patients that are looking 
to receive LLLT, and may not be readily 
accessible. In order to facilitate introducing 
LLLT into mainstream medicine, recent studies 
have analyzed the use of low-power Light 
Emitting Diodes (LEDs) as an alternative 
illumination source to the high-powered lasers 
that are currently used (1, 20, 27). 
This in vitro study validates the proof 
of concept of the bactericidal effects of 
low-irradiance LLLT using visible blue 
low-powered LEDs on cultures of MRSA. 
Photoinactivation of MRSA was achieved 
through LLLT at wavelengths of 405-nm, 
422-nm and 470-nm, as seen in precedent 
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literature (1,10,19-20,23,27).). However, it was 
observed that the optimal wavelength for 
visible blue LLLT was 405-nm (p < 0.0001).. 
The results of this study are consistent 
with the findings of Bumah et al., which 
illustrated that 405-nm photoinactivation 
resulted in a more efficient colony count 
reduction as opposed to other wavelengths 
within the visible blue spectrum (6). 
While multiple studies have confirmed the 
efficacy of LLLT at one discrete wavelength 
or fluence, this study intended to evaluate 
the photoinactivation rates of multiple 
wavelengths to determine the optimal 
wavelength and fluence of LLLT within 
the visible blue spectrum.  As seen in Table 
1 and Fig. 1, 405-nm photoinactivation 
effectively illustrated a more immediate 
bactericidal effect compared to its 422-nm 
and 470-nm counterparts. Despite achieving 
similar bacterial load reductions at each 
wavelength following the entire 300 J/cm2 
light treatment, 405-nm LLLT resulted in a 
94.50% load reduction following its initial 75 
J/cm2 (2 hours) of irradiation. Based on the 
parameters of this phase 1 study, 75 J/cm2 of 
405-nm blue light was determined to be the 
optimal blue light dosage, and was therefore 
held constant throughout phase 2. 
Following phase 1, the irradiance (mW/
cm2) at which the light was delivered to the 
MRSA cultures was manipulated during 
phase 2 to determine if a lower, more 
continuous light exposure could result in 
a maximum formation of reactive oxygen 
species (ROS) through a specific fluence. 
As illustrated in Table 2, low-irradiance 
LLLT provided a statistically significant 
improvement [p < 0.0001] in reducing the 
bacterial load of MRSA, and should be 
considered as a viable, therapeutic alternative 
to high intensity LLLT, which conversely 
deliversthe total fluence over short durations, 
ranging from 60 seconds to 10 minutes. 
Based on this principle, LLLT illumination 
using a high irradiance light source could 
potentially deplete oxygen supplies more 
rapidly than low-irradiance LLLT, and 
therefore compromise the efficacy of the 
intervention (4, 38). Future studies using this 
low-irradiance strategy will add merit to the 
growing body of evidence of the efficacy 
and safety of LLLT.
One of the limitations of this study was 
the inability of the LED apparatus to 
administer a uniform irradiance of less than 
3.48 mW/cm2 to each of the 24-wells due 
to a constraint of the power supply used 
in this experimental setup. Based upon 
the parameters of this study, subsequent 
studies should be completed to evaluate 
the bactericidal effects of LLLT using 
irradiances lower than the 3.48 mW/cm2 to 
determine if there is a minimum threshold 
to low-irradiance that would consequently 
compromise efficacy of treatment. Another 
limitation of the current study was that 
the bactericidal effects of low-irradiance 
LLLT were only evaluated on one strain of 
MRSA. Studies completed by Grinholc et 
al. (13) determined after analyzing over 40 
distinct strains of MRSA that the bactericidal 
effect of LLLT was strain-dependent, with 
bacterial load reduction counts ranging 
from 0% - >99.9% (3 log-reduction) (13). 
While this study did analyze the effects of 
LLLT using a light source in the visible red 
(624-nm) spectrum, subsequent analyses 
of the bactericidal effects of 405-nm low-
irradiance LLLT should be evaluated among 
various Gram-positive and Gram-negative 
organisms, and their respective strains.  
In addition to subsequent studies strictly 
analyzing the efficacy of 405-nm low-
irradiance LLLT for its bactericidal and 
wound healing capabilities, there is a 
growing body of evidence that LLLT 
using multiple wavelengths has provided 
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synergistic effects that benefit the overall 
therapeutic outcomes when compared to 
using solely monochromatic LLLT (12, 14, 
18, 21-22). Studies from Goldberg et al. (12) 
and Lee et al. (18) observed the efficacy 
of visible blue (415+5 nm) and red (633+6 
nm) combination light for the treatment 
of acne vulgaris in a 27 patient study, 
and determined that phototherapy using 
multiple wavelengths was an effective 
strategy to reduce bacterial load as well as 
accelerate skin healing (12, 18). Translating 
the efficacy of combination wavelength 
treatments to other areas of medicine could 
possibly reduce the potential of oral tissue 
infection following oral surgery while 
simultaneously promoting faster healing 
of gingival tissue or additional soft tissues 
within the oral cavity.  Furthermore, 
combination wavelength treatments show 
promise in dermatologic, surgical, and 
military environments where infection 
management, tissue rescue, and tissue 
healing are directly connected to survival 
or other favorable outcomes.
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